![PDF) First-in-man study of paclitaxel-eluting stent BiOSS (Bifurcation Optimisation Stent System) dedicated for coronary bifurcation stenoses: Three months results PDF) First-in-man study of paclitaxel-eluting stent BiOSS (Bifurcation Optimisation Stent System) dedicated for coronary bifurcation stenoses: Three months results](https://www.researchgate.net/profile/Adam-Kern-2/publication/221768468/figure/tbl2/AS:751444609208321@1556169764077/Procedural-characteristics_Q320.jpg)
PDF) First-in-man study of paclitaxel-eluting stent BiOSS (Bifurcation Optimisation Stent System) dedicated for coronary bifurcation stenoses: Three months results
![PDF) First-in-man study of paclitaxel-eluting stent BiOSS (Bifurcation Optimisation Stent System) dedicated for coronary bifurcation stenoses: Three months results PDF) First-in-man study of paclitaxel-eluting stent BiOSS (Bifurcation Optimisation Stent System) dedicated for coronary bifurcation stenoses: Three months results](https://i1.rgstatic.net/publication/221768468_First-in-man_study_of_paclitaxel-eluting_stent_BiOSS_Bifurcation_Optimisation_Stent_System_dedicated_for_coronary_bifurcation_stenoses_Three_months_results/links/5cc1441e4585156cd7afb9ec/largepreview.png)
PDF) First-in-man study of paclitaxel-eluting stent BiOSS (Bifurcation Optimisation Stent System) dedicated for coronary bifurcation stenoses: Three months results
![PDF) First-in-man study of paclitaxel-eluting stent BiOSS (Bifurcation Optimisation Stent System) dedicated for coronary bifurcation stenoses: Three months results PDF) First-in-man study of paclitaxel-eluting stent BiOSS (Bifurcation Optimisation Stent System) dedicated for coronary bifurcation stenoses: Three months results](https://www.researchgate.net/profile/Adam-Kern-2/publication/221768468/figure/tbl1/AS:751444609216512@1556169764048/Patient-population-demographic-characteristics_Q320.jpg)